Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$264K |
| 2 |
JPMorgan Chase
JPM
|
+$248K |
| 3 |
Microsoft
MSFT
|
+$244K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$199K |
| 5 |
PNC Financial Services
PNC
|
+$154K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.86M |
| 2 |
GSK
GSK
|
+$3.83M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$3.37M |
| 4 |
Seaboard Corp
SEB
|
+$1.74M |
| 5 |
BP
BP
|
+$1.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.94% |
| 2 | Financials | 30.23% |
| 3 | Communication Services | 19.12% |
| 4 | Energy | 8.85% |
| 5 | Consumer Staples | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Citigroup
C
$221B
| $102M | 18.11% |
876,278
-382
| -0% | -$39.7K |
|
|
BAY
2
DELISTED
BAYER AG SPONS ADR
BAY
| $73.1M | 12.94% |
6,754,291
-32,962
| -0.5% | -$357K |
|
|
FLG
3
Flagstar Bank National Association
FLG
$5.59B
| $52.6M | 9.31% |
4,177,212
-119,540
| -3% | -$1.43M |
|
4
Merck
MRK
$376B
| $45.3M | 8.02% |
430,103
-3,647
| -0.8% | -$342K |
|
5
Walt Disney
DIS
$186B
| $44.9M | 7.95% |
394,369
-155
| -0% | -$17.1K |
|
|
6
Alphabet (Google) Class C
GOOG
$4.18T
| $42.5M | 7.52% |
135,416
+694
| +0.5% | +$199K |
|
|
7
BP
BP
$115B
| $36.1M | 6.39% |
1,038,402
-47,205
| -4% | -$1.66M |
|
|
8
Seaboard Corp
SEB
$4.08B
| $32.4M | 5.73% |
7,285
-439
| -6% | -$1.74M |
|
9
Organon & Co
OGN
$3.61B
| $26M | 4.61% |
3,629,451
+12,606
| +0.3% | +$99.6K |
|
10
IDT Corp
IDT
$1.69B
| $20.1M | 3.55% |
392,011
-346
| -0.1% | -$17.3K |
|
|
11
Pfizer
PFE
$160B
| $13.8M | 2.44% |
553,950
-153,194
| -22% | -$3.86M |
|
|
SEG
12
Seaport Entertainment Group
SEG
$344M
| $11.6M | 2.05% |
586,170
+2,806
| +0.5% | +$62.9K |
|
|
13
Bristol-Myers Squibb
BMY
$137B
| $10.9M | 1.93% |
202,196
-70,138
| -26% | -$3.37M |
|
14
Patterson-UTI
PTEN
$4.71B
| $10.6M | 1.88% |
1,742,013
-143,447
| -8% | -$856K |
|
|
15
GSK
GSK
$105B
| $8.76M | 1.55% |
178,696
-82,141
| -31% | -$3.83M |
|
16
MBIA
MBI
$250M
| $7.37M | 1.3% |
1,028,784
-1,010
| -0.1% | -$7.3K |
|
17
Genie Energy
GNE
$395M
| $2.62M | 0.46% |
190,312
-1,560
| -0.8% | -$23K |
|
|
18
ExxonMobil
XOM
$679B
| $2.43M | 0.43% |
20,217
+2,274
| +13% | +$264K |
|
|
FFH
19
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
| $1.94M | 0.34% |
1,018
| – | – |
|
20
Novartis
NVS
$302B
| $1.89M | 0.33% |
13,678
-648
| -5% | -$84.9K |
|
|
WBS
21
DELISTED
Webster Financial
WBS
| $1.88M | 0.33% |
29,833
-340
| -1% | -$20.2K |
|
22
CSX Corp
CSX
$95.6B
| $1.36M | 0.24% |
37,531
-3,200
| -8% | -$115K |
|
|
23
Microsoft
MSFT
$3.59T
| $1.16M | 0.2% |
2,392
+487
| +26% | +$244K |
|
|
24
JPMorgan Chase
JPM
$935B
| $1.12M | 0.2% |
3,468
+800
| +30% | +$248K |
|
25
Apple
AAPL
$4.51T
| $841K | 0.15% |
3,092
+100
| +3% | +$26.8K |
|
Similar funds
Kahn Brothers's Q4 2025 Portfolio in Review
As of Q4 2025, Kahn Brothers held 54 positions worth $565M, up 6.2% from $532M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 1.9%. Kahn Brothers opened 1 new position and made no exits, leaving the 54-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Financials and Communication Services.
- Kahn Brothers added most to ExxonMobil in Q4 2025, an estimated $264K increase.
- Kahn Brothers's biggest Q4 2025 reduction was Pfizer, cutting an estimated $3.86M.
- Kahn Brothers's ten largest holdings make up 84% of its $565M portfolio in Q4 2025.
- Kahn Brothers opened 1 new position and closed 0 in Q4 2025.
- Kahn Brothers's portfolio value rose 6.2% quarter-over-quarter to $565M.
Based on Kahn Brothers Group's 13F filing for Q4 2025, filed 12 Feb 2026.